Pathophysiology of lymphedema - Is there a chance for medication treatment? Conference Paper


Authors: Hespe, G. E.; Nores, G. G.; Huang, J. J.; Mehrara, B. J.
Title: Pathophysiology of lymphedema - Is there a chance for medication treatment?
Conference Title: 5th World Symposium for Lymphedema Surgery (WSLS)
Abstract: Lymphedema is a common morbid after cancer treatment. The disease characterizes with progressive inflammatory process that result in irreversible fibrosis. Its chronology and progressive disease character often impacts the quality of life of cancer survivors. The pathophysiology of lymphedema remains unclear and the disease remains non-curable. In this article, we reviewed available studies of lymphedema and concluded possible treatment strategies for lymphedema. J. Surg. Oncol. 2017;115:96–98. © 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.
Keywords: inflammation; lymphedema; t-cell
Journal Title Journal of Surgical Oncology
Volume: 115
Issue: 1
Conference Dates: 2016 Apr 27-29
Conference Location: Linkou, Taiwan
ISBN: 0022-4790
Publisher: Wiley Blackwell  
Date Published: 2017-01-01
Start Page: 96
End Page: 98
Language: English
DOI: 10.1002/jso.24414
PROVIDER: scopus
PUBMED: 27566412
DOI/URL:
Notes: Review -- Export Date: 2 February 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Babak Mehrara
    448 Mehrara
  2. Geoffrey Eckerson Hespe
    23 Hespe
  3. Jung Ju   Huang
    5 Huang